Experts in Leukemia and Blood Cancer

Working with many rare forms of blood disorders, the Stanford Hematology Program brings together a multispecialty team of experts dedicated to treating leukemia as well as other benign and malignant hematologic disorders.

Hematology Program
875 Blake Wilbur Drive
Palo Alto, CA 94304
Phone: 650-498-6000 Getting Here
Maps & Directions
875 Blake Wilbur Drive
Palo Alto, CA 94304
Phone: 650-498-6000 Getting Here

Our Doctors

Care and Treatment of Leukemia and Blood Cancers

Treatment for Leukemia

Offering state-of-the-art chemotherapy protocols for leukemia and other hematologic malignancies, as well as working seamlessly with Stanford's highly-acclaimed Blood and Marrow Transplant Program, the Hematology Program strives to assure the best possible outcome for patients. Our goal is to improve the survival and quality of life of patients, and Stanford hematologists were instrumental in the development of the National Comprehensive Cancer Network (NCCN) guidelines for the management of hematologic malignancies.

Treatment options

  • State-of-the-art surgical techniques to address metastatic tumors
  • Advanced minimally invasive surgery, including use of robotics to enhance complex procedures, minimize patient stays, and speed recovery times
  • Intraoperative radiation therapy (IORT), which delivers high-dose radiation directly to a patient's tumor site during surgery
  • New and investigational treatments, including PARP inhibitors, immunotherapies such as dendritic cell therapy, and ovarian cancer vaccines
  • Fertility-conserving surgery and advanced assisted reproductive technology to help maximize your childbearing options

Blood and bone marrow transplant

A specialized therapy to transfer healthy bone marrow cells into a patient after their own unhealthy bone marrow has been eliminated.


The use of anticancer drugs to shrink or kill cancerous cells and reduce cancer spreading to other parts of the body.


Immunotherapy (also called biological therapy, biological response modifier therapy, or biotherapy) is designed to boost the body's immune system in order to fight cancer. The cells, antibodies, and organs of the immune system work to protect and defend the body against foreign invaders, such as bacteria or viruses. Doctors and researchers have found that the immune system might also be able to both determine the difference between healthy cells and cancer cells in the body, and to eliminate the cancer cells.

Radiation therapy

The use of high-energy radiation to kill or shrink cancer cells, tumors, and non-cancerous diseases.

Stem cell transplant for cancers

A method of replacing blood-forming cells destroyed by cancer treatment to help the bone marrow recover and continue to make healthy blood cells.

Clinical Trials

Leading research

Through their laboratory investigation and clinical research, Stanford Hematology Program clinicians are identifying the biologic mechanisms responsible for the development of hematological disorders and developing more effective therapies to address these diseases. Additionally, our doctors are engaged a number of clinical trials through the Southwest Oncology Group and the Eastern Cooperative Oncology Group, as well as in Stanford-based studies.

Innovative research in clinical trials

Stanford has an extensive portfolio of clinical trials using novel therapies and investigational agents for all types of leukemia, multiple myeloma, and myelopfoliferative neoplasms.

Clinical trial participation

Doctors from the Division of Hematology are engaged a number of clinical trials through the Southwest Oncology Group and the Eastern Cooperative Oncology Group, as well as in Stanford-based studies. Some of our current clinical trials include:

  • Antibody therapy for chronic lymphocytic leukemia
  • Arsenic trioxide for promyelocytic leukemia
  • Anti-angiogenesis therapies (treatments that seek to prevent tumors from generating new blood supplies to nourish themselves)

Before beginning treatment, ask your doctor about any clinical trials you should consider. Learn more about clinical trials for cancer patients.

Clinical trial eligibility flowcharts

Eligibility flowcharts map clinical trials to specific types of cancers to determine if a participant is eligible for the particular clinical trial. View all hematology eligibility flowcharts at the Stanford Cancer Institute.

For Patients


Review the New Patient Packet for information about:

  • What to expect on the day of your appointment
  • Maps, directions, parking, public transit options, and contact information
  • Other patient resources

Bring completed forms found in the Hematology New Patient Letter.


Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care (formerly Stanford Hospital & Clinics). 

International Patients
Phone: +1 650-723-8561

Call us to make an appointment



For Health Care Professionals


Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8:30 a.m. – 5 p.m.

Stanford Health Care (formerly Stanford Hospital & Clinics) provides comprehensive services to refer and track patients, as well as provides the latest information and news for physicians and office staff. For help with all referral needs and questions visit Referring Physicians.


Fax a referral form with supporting documentation to 650-320-9443.

Please note, though this form is from Stanford Health Care (formerly Stanford Hospital & Clinics), it is also used for all Cancer Center referrals.

Track your patients' progress and communicate with Stanford providers securely online.

Learn More About PRISM »